Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-079376

Chief Scientific Officer sold 16,105 shares at $20.01 ($322,261)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reich Kristian Chief Scientific Officer 2026-07-15 Sale 10b5-1 −16,105 $20.01 $322,261 2,808,446 I
Open-market sales · 16,105 sh · avg $20.01 · $322,261
Loading xslF345X06/ownership.xml…